HHLR ADVISORS, LTD. Prelude Therapeutics Incorporated Transaction History

HHLR ADVISORS, LTD. portfolio value:

$3.85M
portfolio value

HHLR ADVISORS, LTD. quarter portfolio value change:

+26.63%
quarter

Prelude Therapeutics Incorporated 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 811K $6.61 583.33K
Q2 2022 share 0.00% 0 shares -980K $5.22 583.33K
Q1 2022 share 0.00% 0 shares -3.23M $6.9 583.33K
Q4 2021 share 0.00% 0 shares -10.96M $12.76 583.33K
Q3 2021 share 0.00% 0 shares 1.52M $31.25 583.33K
Q2 2021 share Increase 0.00% 583.33K shares 16.70M $28.63 583.33K
Q1 2021 share Decrease -16.47% -123.49K shares -26.51M $43.33 626.50K
Q4 2020 share 0.00% 0 shares 31.06M $71.55 750K
Q3 2020 share Increase 0.00% 750K shares 22.59M $30.13 750K